Matches in Wikidata for { <http://www.wikidata.org/entity/Q64646266> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q64646266 description "clinical trial" @default.
- Q64646266 description "ensayu clínicu" @default.
- Q64646266 description "klinisch onderzoek" @default.
- Q64646266 description "клінічне випробування" @default.
- Q64646266 name "Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults" @default.
- Q64646266 type Item @default.
- Q64646266 label "Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults" @default.
- Q64646266 prefLabel "Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults" @default.
- Q64646266 P1132 Q64646266-B3429191-4DC1-46F4-A4B2-86D18D0363E4 @default.
- Q64646266 P131 Q64646266-8DB9E206-715D-4A14-8EAD-42F1F72007E1 @default.
- Q64646266 P1476 Q64646266-843BCDE6-9225-414D-8E5C-2B0CE710A9B6 @default.
- Q64646266 P17 Q64646266-A5BF293F-063D-4008-BAA1-85340FB0CDF3 @default.
- Q64646266 P2899 Q64646266-DCF5314F-D006-4AF5-BCBC-E99259475859 @default.
- Q64646266 P3098 Q64646266-EDF9FA84-DEB8-48A8-B6DA-FE81A46808D3 @default.
- Q64646266 P31 Q64646266-4A812452-24A4-4DE3-851D-FDCA74CAEAF8 @default.
- Q64646266 P4844 Q64646266-E943D49D-916E-465B-A820-260624DFE0C2 @default.
- Q64646266 P580 Q64646266-25DFE37C-990A-4219-88C3-37C25F607A6E @default.
- Q64646266 P582 Q64646266-F850CA77-9C3E-457E-B6A8-84DCD2B004F8 @default.
- Q64646266 P6099 Q64646266-91BDE3D2-6C74-4D5F-9F69-01F97A10EEE2 @default.
- Q64646266 P6153 Q64646266-3A51503C-740F-45A5-BBFF-69F8333CD92C @default.
- Q64646266 P6153 Q64646266-791977D9-1782-4017-9F74-EC3F6B4B1A92 @default.
- Q64646266 P6153 Q64646266-87EF79A0-5CA6-47B7-B2C9-F388DAB28DFE @default.
- Q64646266 P6153 Q64646266-8FDEF5CA-7862-4783-B83C-5EAB3ACADB12 @default.
- Q64646266 P6153 Q64646266-91B95108-BD78-4685-B88D-2D398EE8D570 @default.
- Q64646266 P6153 Q64646266-C0618B71-5B7D-4D24-AB83-58DB2379F186 @default.
- Q64646266 P6153 Q64646266-CBF7181E-EB73-4AC6-B7F3-F5B3B002EF6A @default.
- Q64646266 P8363 Q64646266-266ACB03-07BB-49F8-BEF1-B4463F12E019 @default.
- Q64646266 P1132 "+279" @default.
- Q64646266 P131 Q1183 @default.
- Q64646266 P1476 "A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen Versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen in HIV-1 Infected, Antiretroviral Treatment-Naive Adults" @default.
- Q64646266 P17 Q30 @default.
- Q64646266 P2899 "+18" @default.
- Q64646266 P3098 "NCT01497899" @default.
- Q64646266 P31 Q30612 @default.
- Q64646266 P4844 Q29005900 @default.
- Q64646266 P580 "2011-12-28T00:00:00Z" @default.
- Q64646266 P582 "2012-10-17T00:00:00Z" @default.
- Q64646266 P6099 Q42824440 @default.
- Q64646266 P6153 Q1721601 @default.
- Q64646266 P6153 Q2900977 @default.
- Q64646266 P6153 Q30270271 @default.
- Q64646266 P6153 Q30279912 @default.
- Q64646266 P6153 Q41506 @default.
- Q64646266 P6153 Q5714832 @default.
- Q64646266 P6153 Q5721418 @default.
- Q64646266 P8363 Q78089383 @default.